Quadrant Capital Group LLC Intellia Therapeutics, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 43 shares of NTLA stock, worth $523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 613 92.99%
Holding current value
$523
Previous $13,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$19.72 - $27.36 $11,240 - $15,595
-570 Reduced 92.99%
43 $0
Q2 2024

Aug 12, 2024
BUY
$20.02 - $27.22 $4,624 - $6,287
231 Added 60.47%
613 $13,000
Q1 2024

May 15, 2024
SELL
$23.82 - $32.8 $2,239 - $3,083
-94 Reduced 19.75%
382 $10,000
Q4 2023

Feb 08, 2024
BUY
$23.16 - $32.34 $10,097 - $14,100
436 Added 1090.0%
476 $14,000
Q3 2023

Nov 14, 2023
BUY
$31.62 - $45.78 $284 - $412
9 Added 29.03%
40 $1,000
Q2 2023

Aug 09, 2023
SELL
$34.58 - $46.03 $5,740 - $7,640
-166 Reduced 84.26%
31 $1,000
Q1 2023

May 11, 2023
BUY
$33.3 - $44.82 $5,960 - $8,022
179 Added 994.44%
197 $7,000
Q4 2022

Feb 10, 2023
SELL
$33.21 - $62.69 $4,915 - $9,278
-148 Reduced 89.16%
18 $0
Q2 2022

Aug 09, 2022
BUY
$38.49 - $76.21 $5,003 - $9,907
130 Added 361.11%
166 $9,000
Q1 2022

May 06, 2022
SELL
$58.27 - $118.99 $1,456 - $2,974
-25 Reduced 40.98%
36 $3,000
Q4 2021

Feb 01, 2022
SELL
$100.76 - $138.36 $7,960 - $10,930
-79 Reduced 56.43%
61 $7,000
Q3 2021

Nov 12, 2021
BUY
$132.37 - $176.78 $10,589 - $14,142
80 Added 133.33%
140 $19,000
Q2 2021

Aug 09, 2021
BUY
$60.88 - $161.91 $1,704 - $4,533
28 Added 87.5%
60 $10,000
Q1 2021

May 12, 2021
BUY
$46.59 - $83.68 $1,490 - $2,677
32 New
32 $3,000
Q2 2020

Aug 13, 2020
SELL
$11.14 - $22.87 $167 - $343
-15 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$9.44 - $15.58 $141 - $233
15 New
15 $0

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email